Shaping the Next Generation of Healthcare and Pharmaceuticals with Space Solutions

In recent years, the pharmaceutical and healthcare industries have faced growing pressure to improve sustainability, digitalisation, and resilience. Initiatives such as the WHO’s One Health highlight the urgency of tackling environmental and health risks like antimicrobial resistance and pollution. Space technologies offer crucial support: Earth Observation (EO) can monitor the impact of drugs on the environment, water quality, and weather conditions affecting the spread of disease; while GNSS facilitates the collection of expired drugs and the precise tracking of medicines and waste. SatCom supports remote data exchange, telemedicine, and real-time adaptation of treatments via digital twins (DT). In healthcare, EO, AR/VR, and satellite-enabled AI tools enhance diagnostics, patient monitoring, and surgical planning. Additionally, microgravity research aboard the ISS accelerates drug development and disease modeling. Platforms like ESA's Business in Space Growth Network (BSGN) enable biotech R&D in space, improving treatments and drug development.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

1. Item 1
2. Item 2
3. Item 3

Unordered list

• Item A
• Item B
• Item C

Text link

Bold text

Emphasis

^Superscript

_Subscript